Public Joint-Stock Company "Pharmsynthez" (LIFE.ME)
RUB 4.22
(1.2%)
RUB 4.22
(1.2%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 1.21 Billion RUB | 12.65% |
| 2021 | 1.08 Billion RUB | 4.06% |
| 2020 | 1.03 Billion RUB | -38.41% |
| 2019 | 1.68 Billion RUB | 4.01% |
| 2018 | 1.62 Billion RUB | 2.03% |
| 2017 | 1.58 Billion RUB | 39.37% |
| 2016 | 1.13 Billion RUB | 53.91% |
| 2015 | 740.32 Million RUB | 225.0% |
| 2014 | 227.79 Million RUB | -48.2% |
| 2013 | 439.78 Million RUB | 135.57% |
| 2012 | 186.68 Million RUB | -0.17% |
| 2011 | 187 Million RUB | -69.3% |
| 2010 | 609.02 Million RUB | 481.35% |
| 2009 | 104.76 Million RUB | -12.78% |
| 2008 | 120.11 Million RUB | 6.92% |
| 2007 | 112.33 Million RUB | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q1 | 1.07 Billion RUB | -11.35% |
| 2023 Q2 | 1.07 Billion RUB | 0.0% |
| 2022 Q2 | 1 Billion RUB | 0.0% |
| 2022 Q3 | 1.21 Billion RUB | 21.01% |
| 2022 Q4 | 1.21 Billion RUB | 0.0% |
| 2022 Q1 | 1 Billion RUB | -6.91% |
| 2022 FY | 1.21 Billion RUB | 12.65% |
| 2021 Q2 | 1.11 Billion RUB | -0.0% |
| 2021 FY | 1.08 Billion RUB | 4.06% |
| 2021 Q3 | 1.08 Billion RUB | -3.1% |
| 2021 Q4 | 1.08 Billion RUB | 0.0% |
| 2021 Q1 | 1.11 Billion RUB | 7.38% |
| 2020 Q1 | 1.08 Billion RUB | 2.25% |
| 2020 Q3 | 1.03 Billion RUB | -4.38% |
| 2020 Q4 | 1.03 Billion RUB | 0.0% |
| 2020 FY | 1.03 Billion RUB | -38.41% |
| 2020 Q2 | 1.08 Billion RUB | -0.0% |
| 2019 Q2 | 1.64 Billion RUB | 63.57% |
| 2019 FY | 1.68 Billion RUB | 4.01% |
| 2019 Q4 | 1.06 Billion RUB | 0.0% |
| 2019 Q3 | 1.06 Billion RUB | -35.44% |
| 2019 Q1 | 1 Billion RUB | -6.65% |
| 2018 FY | 1.62 Billion RUB | 2.03% |
| 2018 Q4 | 1.07 Billion RUB | 0.0% |
| 2018 Q3 | 1.07 Billion RUB | -39.23% |
| 2018 Q2 | 1.77 Billion RUB | 0.0% |
| 2018 Q1 | 1.77 Billion RUB | 11.61% |
| 2017 Q1 | - RUB | -100.0% |
| 2017 FY | 1.58 Billion RUB | 39.37% |
| 2017 Q4 | 1.58 Billion RUB | 0.0% |
| 2017 Q3 | 1.58 Billion RUB | 50.66% |
| 2017 Q2 | 1.05 Billion RUB | 0.0% |
| 2016 Q1 | 1.05 Billion RUB | 42.37% |
| 2016 Q3 | 1.05 Billion RUB | 0.16% |
| 2016 Q4 | 1.13 Billion RUB | 7.93% |
| 2016 Q2 | 1.05 Billion RUB | 0.0% |
| 2016 FY | 1.13 Billion RUB | 53.91% |
| 2015 Q1 | 305.19 Million RUB | 33.98% |
| 2015 Q4 | 740.32 Million RUB | 0.0% |
| 2015 Q3 | 740.32 Million RUB | 142.57% |
| 2015 Q2 | 305.19 Million RUB | 0.0% |
| 2015 FY | 740.32 Million RUB | 225.0% |
| 2014 Q1 | 801.02 Million RUB | 82.14% |
| 2014 Q4 | 227.79 Million RUB | 6.65% |
| 2014 FY | 227.79 Million RUB | -48.2% |
| 2014 Q3 | 213.6 Million RUB | 28.11% |
| 2014 Q2 | 166.73 Million RUB | -79.19% |
| 2013 Q3 | 439.78 Million RUB | -8.37% |
| 2013 FY | 439.78 Million RUB | 135.57% |
| 2013 Q4 | 439.78 Million RUB | 0.0% |
| 2013 Q2 | 479.94 Million RUB | 0.0% |
| 2012 Q4 | 186.68 Million RUB | 0.0% |
| 2012 FY | 186.68 Million RUB | -0.17% |
| 2011 FY | 187 Million RUB | -69.3% |
| 2010 FY | 609.02 Million RUB | 481.35% |
| 2009 FY | 104.76 Million RUB | -12.78% |
| 2008 FY | 120.11 Million RUB | 6.92% |
| 2007 FY | 112.33 Million RUB | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|